Swamponomics: Trump’s Fed Pick, a Kodak Moment, and GDP Misinformation

Kodak’s newly announced $765 million loan is just another case of DC picking winners and losers.

President Donald Trump and his administration recently announced that Kodak would be transformed into a pharmaceutical producer under the Defense Production Act (DPA). The president confirmed that Kodak would receive a $765 million loan to establish Kodak Pharmaceuticals to manufacture generic pharmaceutical ingredients to decrease America’s reliance on foreign drug makers. If you have not been paying attention to Kodak’s transformation, you might be surprised that a film and camera maker from back in the day is now producing pharmaceuticals. But the business filed for bankruptcy in 2012 and turned itself into a materials and chemical company.